Company going through dramatic change under the PE owners - Recensione dipendente - Dipendente anonimo presso IQVIA

1,0
8 set 2012
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Well respected company and presence in 80 plus countries. Critical to pharma industry functioning

Svantaggi

Arrogance of being IMS is a big bottleneck. Not an employee friendly company and only targets matter. Over evaluative and living in 1960's

Esplora altre recensioni su IQVIA

5,0
26 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Full remote work at home, 401(k)

Svantaggi

No PTO of HSA benefits

1,0
30 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Remote work option is nice to have

Svantaggi

Zero support from management, with employee development and team concerns often taking a back seat to other priorities. Morale continues to go downhill, and several colleagues exploring opportunities elsewhere or leaving the organization already. The culture is challenging, particularly around providing candid feedback, as employees often are tracker down and face negative repercussions and retaliations. Career advancement depends more on aligning with leadership preferences than on merit and performance. Would not recommend this company to those seeking a supportive environment with transparent growth opportunities. Overall, the culture is political and difficult to navigate.

Vedi recensioni per: Utile|Valutazione|Data|Tutto